[1] Rongshou ZHENG, Kexin SUN, Siwei ZHANG et al. Report of cancer epidemiology in China, 2015. Chinese Journal of Oncology, 41, 19-28(2019).

[2] Q Tang, M Çağlayan. The scaffold protein XRCC1 stabilizes the formation of polβ/gap DNA and ligase Ⅲα/nick DNA complexes in base excision repair. Journal of Biological Chemistry, 297, 101025(2021).

[3] L Gong, M Luo, R H Sun et al. Significant association between XRCC1 expression and its rs25487 polymorphism and radiotherapy-related cancer prognosis. Frontiers in Oncology, 11, 654784(2021).

[4] N Thakur, K Yim, J Abdul-Ghafar et al. High poly(ADP-ribose) polymerase expression does relate to poor survival in solid cancers: a systematic review and meta-analysis. Cancers, 13, 5594(2021).

[5] Y W Zhang, S W Dong, R P Xu et al. Prognostic and predictive role of COX-2, XRCC1 and RASSF1 expression in patients with esophageal squamous cell carcinoma receiving radiotherapy. Oncology Letters, 13, 2549-2556(2017).

[6] Y J Niu, X Zhang, Y X Zheng et al. XRCC1 deficiency increased the DNA damage induced by γ-ray in HepG2 cell: involvement of DSB repair and cell cycle arrest. Environmental Toxicology and Pharmacology, 36, 311-319(2013).

[7] Z C Wu, X Y Miao, Y F Zhang et al. XRCC1 is a promising predictive biomarker and facilitates chemo-resistance in gallbladder cancer. Frontiers in Molecular Biosciences, 7, 70(2020).

[8] K Hastak, S Bhutra, R Parry et al. Poly (ADP-ribose) polymerase inhibitor, an effective radiosensitizer in lung and pancreatic cancers. Oncotarget, 8, 26344-26355(2017).

[9] F Y Feng, C Speers, M L Liu et al. Targeted radiosensitization with PARP1 inhibition: optimization of therapy and identification of biomarkers of response in breast cancer. Breast Cancer Research and Treatment, 147, 81-94(2014).

[10] S Mueller, S Bhargava, A M Molinaro et al. Poly (ADP-Ribose) polymerase inhibitor MK-4827 together with radiation as a novel therapy for metastatic neuroblastoma. Anticancer Research, 33, 755-762(2013).

[11] A A Demin, K Hirota, M Tsuda et al. XRCC1 prevents toxic PARP1 trapping during DNA base excision repair. Molecular Cell, 81, 3018-3030.e5(2021).

[12] I Rashid, M Hammel, A Sverzhinsky et al. Direct interaction of DNA repair protein tyrosyl DNA phosphodiesterase 1 and the DNA ligase Ⅲ catalytic domain is regulated by phosphorylation of its flexible N-terminus. Journal of Biological Chemistry, 297, 100921(2021).

[13] I A Vasil'eva, N A Moor, O I Lavrik. Effect of human XRCC1 protein oxidation on the functional activity of its complexes with the key enzymes of DNA base excision repair. Biochemistry (Moscow), 85, 288-299(2020).

[14] W M Wang, J J Yang, Y Yu et al. Expression of JWA and XRCC1 as prognostic markers for gastric cancer recurrence. International Journal of Clinical and Experimental Pathology, 13, 3120-3127(2020).

[15] J M Pascal. The comings and goings of PARP-1 in response to DNA damage. DNA Repair, 71, 177-182(2018).

[16] H Hanzlikova, I Kalasova, A A Demin et al. The importance of poly(ADP-ribose) polymerase as a sensor of unligated Okazaki fragments during DNA replication. Molecular Cell, 71, 319-331.e3(2018).

[17] R Abbotts, Wilson D M Ⅲ. Coordination of DNA single strand break repair. Free Radical Biology and Medicine, 107, 228-244(2017).

[18] M Tallis, R Morra, E Barkauskaite et al. Poly(ADP-ribosyl)ation in regulation of chromatin structure and the DNA damage response. Chromosoma, 123, 79-90(2014).

[19] C Breslin, P Hornyak, A Ridley et al. The XRCC1 phosphate-binding pocket binds poly (ADP-ribose) and is required for XRCC1 function. Nucleic Acids Research, 43, 6934-6944(2015).

[20] A Kumar, A J Reed, W J Zahurancik et al. Interlocking activities of DNA polymerase β in the base excision repair pathway. Proceedings of the National Academy of Sciences of the United States of America, 119, e2118940119(2022).

[21] L M Polo, Y Q Xu, P Hornyak et al. Efficient single-strand break repair requires binding to both poly(ADP-ribose) and DNA by the central BRCT domain of XRCC1. Cell Reports, 26, 573-581.e5(2019).

[22] O I Lavrik. PARPs' impact on base excision DNA repair. DNA Repair, 93, 102911(2020).

[23] R Ali, M Alabdullah, A Alblihy et al. PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers. Cancer Letters, 469, 124-133(2020).

[24] A D D'Andrea. Mechanisms of PARP inhibitor sensitivity and resistance. DNA Repair, 71, 172-176(2018).

[25] R Ferrara, F Simionato, C Ciccarese et al. The development of PARP as a successful target for cancer therapy. Expert Review of Anticancer Therapy, 18, 161-175(2018).

[26] P C Fong, D S Boss, T A Yap et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. The New England Journal of Medicine, 361, 123-134(2009).

[27] J A Nickoloff, N Sharma, L Taylor. Clustered DNA double-strand breaks: biological effects and relevance to cancer radiotherapy. Genes, 11, 99(2020).

[28] J M Reber, J Božić-Petković, M Lippmann et al. PARP1 and XRCC1 exhibit a reciprocal relationship in genotoxic stress response. Cell Biology and Toxicology, 1-20(2022).

[29] C B Prasad, S B Prasad, S S Yadav et al. Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property. Scientific Reports, 7, 12876(2017).

[30] E A Cho, Y S Juhnn. The cAMP signaling system inhibits the repair of γ-ray-induced DNA damage by promoting Epac1-mediated proteasomal degradation of XRCC1 protein in human lung cancer cells. Biochemical and Biophysical Research Communications, 422, 256-262(2012).

[31] P J Mei, J Bai, F A Miao et al. Relationship between expression of XRCC1 and tumor proliferation, migration, invasion, and angiogenesis in glioma. Investigational New Drugs, 37, 646-657(2019).

[32] S Rezapoor, A Shirazi, S Abbasi et al. Modulation of radiation-induced base excision repair pathway gene expression by melatonin. Journal of Medical Physics, 42, 245-250(2017).

[33] M Toulany, K Dittmann, B Fehrenbacher et al. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro. DNA Repair, 7, 1746-1756(2008).

[34] R X Huang, P K Zhou. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduction and Targeted Therapy, 5, 60(2020).